首页> 外文期刊>Radiation oncology >Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
【24h】

Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis

机译:非小细胞肺癌调强放射治疗(IMRT)与3D适形放射治疗(3D-CRT)相比,场外淋巴结站的剂量分布和肿瘤控制概率:计算机分析

获取原文
获取外文期刊封面目录资料

摘要

Background The advent of IMRT and image-guided radiotherapy (IGRT) in combination with involved-field radiotherapy (IF-RT) in inoperable non-small-cell lung cancer results in a decreased incidental dose deposition in elective nodal stations. While incidental nodal irradiation is considered a relevant by-product of 3D-CRT to control microscopic disease this planning study analyzed the impact of IMRT on dosimetric parameters and tumor control probabilities (TCP) in elective nodal stations in direct comparison with 3D-CRT. Methods and materials The retrospective planning study was performed on 41 patients with NSCLC (stages II-III). The CTV was defined as the primary tumor (GTV?+?3?mm) and all FDG-PET-positive lymph node stations. As to the PTV (CTV?+?7?mm), both an IMRT plan and a 3D-CRT plan were established. Plans were escalated until the pre-defined dose-constraints of normal tissues (spinal cord, lung, esophagus and heart) were reached. Additionally, IMRT plans were normalized to the total dose of the corresponding 3D-CRT. For two groups of out-of-field mediastinal node stations (all lymph node stations not included in the CTV (LN all_el ) and those directly adjacent to the CTV (LN adj_el )) the equivalent uniform dose (EUD) and the TCP (for microscopic disease a D50 of 36.5?Gy was assumed) for the treatment with IMRT vs 3D-CRT were calculated. Results In comparison, a significantly higher total dose for the PTV could be achieved with the IMRT planning as opposed to conventional 3D-CRT planning (74.3?Gy vs 70.1?Gy; p?=?0.03). In identical total reference doses, the EUD of LN adj_el is significantly lower with IMRT than with 3D-CRT (40.4?Gy vs. 44.2?Gy. P?=?0.05) and a significant reduction of TCP with IMRT vs 3D-CRT was demonstrated for LN all_el and LN adj_el (12.6?% vs. 14.8?%; and 23.6?% vs 27.3?%, respectively). Conclusions In comparison with 3D-CRT, IMRT comes along with a decreased EUD in out-of-field lymph node stations. This translates into a statistically significant decrease in TCP-values. Yet, the combination of IF-RT and IMRT leads to a significantly better sparing of normal tissues and higher total doses whereas the potential therapeutic drawback of decreased incidental irradiation of elective lymph nodes is moderate.
机译:背景技术在无法手术的非小细胞肺癌中,IMRT和图像引导放疗(IGRT)联合累及场放疗(IF-RT)的出现导致选择性结节中偶然剂量沉积的减少。尽管偶然的淋巴结照射被认为是控制3D-CRT的相关副产品,但这项计划研究与3D-CRT进行了直接比较,分析了IMRT对选择性淋巴结站剂量参数和肿瘤控制概率(TCP)的影响。方法和材料对41例NSCLC患者(II-III期)进行了回顾性规划研究。 CTV定义为原发性肿瘤(GTV≥3mm)和所有FDG-PET阳性的淋巴结站。对于PTV(CTV≥7mm),既建立了IMRT计划又建立了3D-CRT计划。逐步增加计划,直到达到正常组织(脊髓,肺,食道和心脏)的预定剂量约束。此外,IMRT计划已标准化为相应3D-CRT的总剂量。对于两组野外纵隔淋巴结站(CTV中未包括的所有淋巴结站(LN all_el )和与CTV直接相邻的那些淋巴结站(LN adj_el ) ))计算出IMRT与3D-CRT的等效均等剂量(EUD)和TCP(对于微观疾病,假设D50为36.5?Gy)。结果与之相比,IMRT计划可实现PTV显着更高的总剂量,这与传统的3D-CRT计划相反(74.3?Gy与70.1?Gy; p?=?0.03)。在相同的总参考剂量下,IMRT的LN adj_el 的EUD显着低于3D-CRT(40.4?Gy与44.2?Gy。P?=?0.05),并且TCP显着降低LRT all_el 和LN adj_el 分别使用IMRT和3D-CRT进行了验证(分别为12.6%和14.8%; 23.6%和27.3%)。结论与3D-CRT相比,IMRT伴随场外淋巴结站的EUD减少。这转化为TCP值的统计显着下降。然而,IF-RT和IMRT的组合可显着改善正常组织的备用性和更高的总剂量,而选择性淋巴结偶然照射减少的潜在治疗缺陷是中等的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号